Our medicines Our science Our stories
Contact us Careers

Americas

Argentina

 Spanish

Brazil

 Portuguese

Canada
English / French

Chile

 Spanish

Colombia

 Spanish

Mexico

 Spanish

Peru

 Spanish

United States

 English

Asia Pacific

Australia

 English

China

 Simplified Chinese

India

 English

Japan

 Japanese

Korea

 Korean

New Zealand

 English

Singapore

 English

Taiwan

 Traditional Chinese

Thailand
English / Thai

Europe

Austria

 German

Belgium
English / Dutch / French

Czech Republic

 Czech

Denmark

 Danish

Finland

 Finnish

France

 French

Germany

 German

Greece

 Greek

Hungary

 Hungarian

Ireland

 English

Italy

 Italian

Luxembourg

 English

Netherlands
English / Dutch

Norway

 Norwegian

Poland

 Polish

Portugal

 Portuguese

Romania

 Romanian

Spain

 Spanish

Sweden

 Swedish

Switzerland
German / French

United Kingdom

 English

Middle East

Israel

 Hebrew

Saudi Arabia
English / Arabic

Turkey

 Turkish

United Arab Emirates
English / Arabic

Other

Other Markets

 Distributor Markets
bmsUScqPageLucene
Our Medicines

Excellence in clinical trials

Developing community-oriented clinical trialists

 

At the BMS Foundation, we believe that improving representation in clinical trials is a critical part of advancing global health. The Robert A. Winn Excellence in Clinical Trials Award Program, established by the Bristol Myers Squibb Foundation, is training the next generation of clinical research scientists, who have the potential to transform the clinical research landscape, with knowledge, skills and competencies in high quality clinical trials, and the unique science of effective community outreach and engagement. It also exposes medical students to clinical research career pathways.

Winn Awards Program snapshot
  • $124.5 MM Investment ($100 MM from BMS Foundation, $24.5 MM from Funding Partners Amgen, Gilead Sciences and Genentech)
  • 316 clinical trial investigators
  • 316 medical students
“
“We believe that this program is not only innovative, but we believe that this program was necessary. The Winn Awards doesn't just do something different. It does a different thing. And that different thing is to create a work force that results in solving the problem, and having an unmet need met of getting people from rural areas and at-risk areas onto clinical trials. This is the training force of tomorrow.”
Robert A. Winn, MD, director, Massey Comprehensive Cancer Center, Virginia Commonwealth University, namesake of and chair of the National Advisory Committee for the Robert A. Winn Excellence in Clinical Trials Award program
”
“
“Through my participation in the program, I hope to ultimately improve patient diversity and outcomes for all globally. People should be aware that doctors want to cover the entire population in clinical trials. It is not one group that we specifically care about, but rather the whole community.”
Beatriz Wills, MD
”
“
“What I love about this program is that we not only have the opportunity to be mentored, but also to be a mentor -- it is a sustainable initiative. We are inspiring soon-to-be physicians to be investigators one day. It is a brilliant, beautiful pipeline.”
Oluwadamilola Oladeru, MD
”
“
“Every clinical trial involves the unknown. Therefore, the currency for clinical trials is trust. Patients have to be able to trust that the researchers have their best interests in mind and are being transparent about what they are doing. And fostering that type of trust requires a real connection.”
Richard Silvera, MD
”
“
“Anytime a patient goes on a clinical trial, that is a gift to humanity -- one patient’s involvement can make a significant impact down the road for all of humanity.”
Michael Goodman, MD
”